Improvement of hypertension and vascular dysfunction by hydroxyhydroquinone-free coffee in a genetic model of hypertension  by Suzuki, Atsushi et al.
FEBS Letters 580 (2006) 2317–2322Improvement of hypertension and vascular dysfunction by
hydroxyhydroquinone-free coﬀee in a genetic model of hypertension
Atsushi Suzukia,*, Akihiko Fujiia, Naoki Yamamotoa, Masaki Yamamotoa, Hideo Ohminamia,
Akiyo Kameyamaa, Yusuke Shibuyaa, Yoshinori Nishizawaa, Ichiro Tokimitsua, Ikuo Saitob
a Biological Science Laboratories, Kao Corporation, 2606 Akabane Ichikai-machi, Tochigi 321-3497, Japan
b Health Center, Keio University, Tokyo, Japan
Received 14 February 2006; revised 7 March 2006; accepted 12 March 2006
Available online 24 March 2006
Edited by Barry HalliwellAbstract Chlorogenic acid, a polyphenol found in coﬀee, has
antihypertensive actions, but epidemiologic data on the eﬀects
of coﬀee on blood pressure are controversial. Speciﬁc coﬀee com-
ponents that inhibit the hypotensive eﬀect of chlorogenic acid and
the physiologic mechanisms underlying the eﬀects of coﬀee with-
out these components were investigated. One component,
hydroxyhydroquinone (HHQ), inhibited the hypotensive eﬀects
of chlorogenic acid in spontaneously hypertensive rats (SHR).
The attenuation of hypertension by HHQ-free coﬀee was associ-
ated with nitric oxide, the suppression of mRNA expression of
NAD(P)H oxidase, and the improvement in endothelium-depen-
dent vasodilation in the aorta. Thus, HHQ-free coﬀee might reg-
ulate vascular tone by improving the bioavailability of nitric
oxide in SHR.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Endothelial function is impaired in diseases such as hyper-
tension, atherosclerosis, and diabetes; and reactive oxygen spe-
cies (ROS) are generally thought to be involved [1]. NAD(P)H
oxidase is considered to be the main source of ROS, an under-
lying factor in vascular disease [2]. A number of studies have
suggested that excess superoxide anions ðO2 Þ react with nitric
oxide (NO), an endothelium-derived relaxing factor, resulting
in the impairment of endothelial function [3,4]. O2 production
is increased in blood vessels of hypertensive animals, including
spontaneously hypertensive rats (SHR) [2]. Thus, a strategy
aimed at regulating ROS production is a therapeutic target
for inhibiting the development and progression of hyperten-
sion [2].Abbreviations: DCC; droplet countercurrent chromatography; GCE,
green coﬀee bean extract; HHQ, hydroxyhydroquinone; HPLC, high
performance liquid chromatography; L-NAME, NG-nitro-L-arginine
methyl ester; NO, nitric oxide; ROS, reactive oxygen species; SHR,
spontaneously hypertensive rat
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doi:10.1016/j.febslet.2006.03.047Epidemiologic studies indicate that the ingestion of vegeta-
bles and fruits inhibits the development of cardiovascular dis-
ease [5]. Flavonoids and other phenols in vegetables and fruits
appear to play an important role in preventing the develop-
ment of circulatory disorders [6]. Chlorogenic acid, a well-
known antioxidative polyphenol, is present in foods such as
coﬀee beans, apples, Western pears, Japanese apricots,
tomatoes, potatoes, and eggplants [7]. Several chlorogenic acid
isomers can be found in coﬀee: the best known of which is 5-
caﬀeoylquinic acid (Fig. 1) [8]. Green coﬀee bean extract
(GCE), a source of chlorogenic acid, reduces blood pressure
in essential hypertensive subjects and in SHR, and improves
vasoreactivity in humans, suggesting that chlorogenic acid
could play a preventative role in vascular disease [9–12]. NO-
mediated vasodilation is partly involved in the hypotensive
mechanism of chlorogenic acid [11].
Epidemiologic studies and interventional trials have demon-
strated that, in spite of an adequate intake of chlorogenic acid
(15–325 mg per cup), the ingestion of roasted coﬀee has little
eﬀect on hypertension or aortic elasticity [13–15]. Coﬀee con-
tains a number of pharmacologically active components
including caﬀeine (1,3,7-trimethylxanthine). Since caﬀeine is
an inducer of hypertension, it has been extensively studied,
but a recent study demonstrated that caﬀeine intake has little
eﬀect on blood pressure in regular coﬀee drinkers [13]. In sharp
contrast, GCE reduces blood pressure in human hypertensives
in spite of a caﬀeine content equal to that in roasted coﬀee
[9,10]. Otherwise, coﬀee intake increases the urinary excretion
of hydrogen peroxide in humans; and a candidate source of
ROS in coﬀee is hydroxyhydroquinone (HHQ; 1,2,4-trihydr-
oxynbenzene) [16] (Fig. 1). Thus, coﬀee contains a prooxida-
tive component that might lead to the breakdown of NO.
These ﬁndings led us to hypothesize that a coﬀee component,
other than caﬀeine, inhibits the hypotensive eﬀect of chloro-
genic acid, and that the elimination of such an inhibitory com-
ponent might permit the preparation of coﬀee that improves
hypertension. To test this hypothesis, we fractionated a coﬀee
solution and investigated the components of the fractions that
interfered with chlorogenic acid-induced antihypertensive ef-
fects in SHR. HHQ was identiﬁed as a candidate component
that prevents chlorogenic acid-induced antihypertension. We
further investigated the antihypertensive eﬀect of HHQ-free
coﬀee, and the mechanisms of action of HHQ-free coﬀee on
the involvement of NO, endothelium-dependent vasodilation,
and the NAD(P)H oxidase expression, which is a major
ROS-producing enzyme in the vasculature.blished by Elsevier B.V. All rights reserved.
Fig. 1. Chemical structures of hydroxyhydroquinone (1,2,4-trihydr-
oxybenzene) and 5-caﬀeoylquinic acid, a representative chlorogenic
acid.
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2.1. Chemicals and materials
5-Caﬀeoylquinic acid (5-CQA), NG-nitro-L-arginine methyl ester
(L-NAME), phenylephrine hydrochloride, and acetylcholine chloride
were purchased from Sigma Chemical Co. (St. Louis, MO). HHQ
was purchased from Wako Pure Chemical Industries (Osaka, Ja-
pan). GCE, a hot-water extract of green coﬀee beans, was purchased
from the T. Hasegawa Corporation (Tokyo, Japan). The main com-
ponent of GCE is chlorogenic acid (28%), and other components in-
cluded caﬀeine (6%), ethanol (5%), water (50%), and others (11%).2.2. Isolation of coﬀee components that inhibit chlorogenic acid-induced
antihypertension
The procedure used for fractionating the preparation is shown in
Fig. 3A. Commercially available decaﬀeinated instant coﬀee was dis-
solved in ion-exchanged water, ﬁltered through a glass ﬁlter under
reduced pressure, and divided into soluble and insoluble fractions.
The soluble fraction was fractionated as follows. The mobile phase
was 0.5% acetic acid. The soluble fraction was dissolved with the
mobile phase, and adsorbed on a Chromatorex ODS column (Fuji
Silysia Chemical, Aichi, Japan), followed by elution with the mobile
phase containing methanol. The following eluates were collected;
fractions 1 and 2 as F1, fractions 3 to 12 as F2, and fractions 13
to 18 as F3. F2 was further divided into fractions 3 to 7 (F2-1)
and fractions 8 to 12 (F2-2). F2-1 was fractionated by preparative
high performance liquid chromatography (HPLC) under the condi-
tions described below. Instrument: HPLC preparative system PLC-
561 (GL Science, Tokyo, Japan), column: Inertsil ODS-3
(B30 · 250 mm, GL Sciences, Tokyo, Japan), eluent: A, 50 mM
AcOH aq.; B, 50 mM AcOH–CH3CN sol., gradient time table: A,
100% (0–30 min), 0% (30–35 min); B, 100% (35–45 min), ﬂow rate:
40 ml/min, temperature: 35C, and detection: UV 258 nm. The
resulting eluates were divided into three fractions based on the
HPLC chromatogram: F2-1-A, retention time (RT) 0 to 8.3 min;
F2-1-B, RT 8.3 to 11 min; and F2-1-C, RT 11 to 46 min. F2-1-B
was fractionated by droplet countercurrent chromatography (DCC)
using the following conditions. Instrument: DCC system DCC-
3000 (Tokyo Rikakiki, Tokyo, Japan), column: glass (B2 mm),
solution supply pump: L-6000 (Hitachi, Tokyo, Japan), fraction
collector: DC-1000 (Tokyo Rikakiki), and solvent: chloroform:
methanol: 50 mM AcOH aq. = 7:13:8. The resulting eluates were
collected into the three fractions described below, concentrated,
and freeze–dried: fractions 1–19 (F2-1-B-a), fractions 20–26 (F2-1-
B-b), and fractions 27–30 (F2-1-B-c).2.3. Removal of HHQ from coﬀee extract
Roasted Columbia beans (Coﬀea robusta) were extracted with hot
water at 95 C or higher, and then cooled to 25 C. The coﬀee extract
was treated with activated charcoal (Japan EnviroChemicals, Osaka,
Japan) to remove low molecular weight compounds including HHQ
by stirring the suspension with for 1 h at room temperature. The acti-
vated charcoal-treated coﬀee extract was then ﬁltered through a mem-
brane ﬁlter and dried under reduced pressure. The chlorogenic acid
content, determined by HPLC, was 25 mg/g powder in the coﬀee that
was not treated with activated charcoal and 27 mg/g powder in acti-
vated charcoal-treated coﬀee. The HHQ content, determined byHPLC, was 62 mg/kg of powder in the coﬀee that was not treated with
activated charcoal and 2 mg/kg of powder in the activated
charcoal-treated coﬀee, in which 97% of HHQ had been removed.
The activated charcoal-treated dried powder was used as HHQ-free
coﬀee in the following experiments.2.4. Blood pressure measurement
Male SHR/Izm rats, a genetic model of hypertension, were pur-
chased from Japan SLC Co., Ltd (Shizuoka, Japan). The Ethics
Review Committee for Animal Experimentation of the Kao Corpora-
tion approved the animal studies. In the single oral administration
studies, SHR (males, 13–14-week-old) were used. GCE, caﬀeinated
instant coﬀee (chlorogenic acid content, 6%; caﬀeine content, 5%),
5-CQA, coﬀee fractions, and HHQ were dissolved in physiological
saline and were orally administered to conscious SHR at 5 ml/kg of
body weight using a stomach probe. The dose of chlorogenic acid
was 200 or 300 mg/kg of body weight, doses at which a stable reduc-
tion in blood pressure was previously reported [11]. To determine
whether HHQ-free coﬀee reduces blood pressure through interactions
with the NO pathway in SHR, the blood pressure response to HHQ-
free coﬀee was determined in SHR pretreated with the NO synthase
inhibitor L-NAME (3 mg/kg, subcutaneous injection into the neck)
before the administration according to a previously described method
[17]. Physiological saline was administered to the control group. The
tail artery systolic blood pressure (SBP) was measured using a non-
invasive blood pressure measurement system, BP-98A (Softron, To-
kyo, Japan), as described previously [11]. The change in systolic
blood pressure (SBP) (%) was calculated by: [(SBP after administra-
tion)  (SBP before administration)] · 100/(SBP before administra-
tion). To study the eﬀects of continuous HHQ-free coﬀee
administration, two groups of SHR (n = 6 per group, 14-week-old
at the initiation of the experiment) were given the control diet or a
dried HHQ-free coﬀee diet (9.3%) for 8 weeks ad libitum. A powdery
CE-2 diet (CLEA Japan, Inc., Tokyo, Japan) was used as the control
diet. Tail arterial SBP was measured at 2 week intervals for 8 weeks.
The chlorogenic acid dose was approximately 300 mg/kg per day.2.5. Ex vivo vascular reactivity
This experiment was performed according to a previously de-
scribed method [18]. At the end of the 8-week experimental period,
the descending thoracic aorta was excised, freed of fat and connec-
tive tissue, cut into rings approximately 2–3 mm in length, and
placed in a gassed (95% O2 and 5% CO2) Krebs–Henseleit solution
with the following composition (in mM): NaCl 110.8, KCl 5.9,
NaHCO3 25.0, MgSO4 1.07, CaCl2 2.49, NaHPO4 2.33, and glucose
11.51. The tissues were maintained at 37 C under a 1-g tension and
equilibrated for 1 h before initiating the experimental protocols.
Vascular reactivity was measured in aortic rings with the functional
endothelium pre-contracted with submaximal concentrations of
phenylephrine (106 M). Endothelium-dependent vasodilation was
evaluated by comparing the concentration response curves to acetyl-
choline (109 M–106 M), and calculated as the percent of precon-
tractile vascular tone. The responses of the tissues were recorded
using isometric transducers (Kishimoto Medical Instruments, Kyoto,
Japan) and recorders (SEKONIC, Tokyo, Japan).2.6. Real-time polymerase chain reaction (PCR)
At the end of the 8-week experimental period, total RNA was iso-
lated from the thoracic aorta with ISOGENe (NIPPON GENE,
Tokyo, Japan) according to a previously described method [19]. To-
tal RNA (50 ng) was reverse-transcribed for cDNA synthesis with
Omniscripte Reverse Transcriptase (Qiagen Inc., Valencia, CA) to
quantify the mRNA expression of NAD(P)H oxidase components;
Nox-2, p22phox, and p47phox, and 36B4 as a control. Real-time
PCR was performed using ABI PRISM-7000 and -7700 Sequence
Detector (PE Applied Biosystems, Tokyo, Japan). TaqMan 1000
RXN Gold with Buﬀer A Pack (PE Applied Biosystems) was used
to detect the PCR. Each set of primers and probes was designed
using Primer Expresse Software v2.0 (PE Applied Biosystems).
The NCBI Blast program (http://www.ncbi.nlm.nih.gov/blast/) was
used to check the sequence speciﬁcity of the primers and probes.
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All values are expressed as means ± S.E. Statistical analyses of the
data were performed using StatView (SAS Institute, Cary, NC). Data
for each group were initially analyzed using the analysis of variance.
When a signiﬁcant F-value (P < 0.05) was obtained, a Dunnett’s test
was performed in a post hoc analysis. Comparisons of the dose–re-
sponse curves were evaluated by the two-way analysis of variance
for repeated measures.Fig. 2. Eﬀect of a single oral administration of coﬀee and green coﬀee
bean extract (GCE) in awake SHR (200 mg/kg chlorogenic acid). The
results are the means ± S.E.M. (n = 6). *P < 0.05 and **P < 0.01 versus
saline or coﬀee group.3. Results
3.1. Antihypertensive eﬀects of roasted coﬀee in SHR
Fig. 2 shows the changes in SBP in SHR after a single oral
administration of GCE and roasted instant coﬀee in which
the dose of chlorogenic acid was 200 mg/kg. The initial SBP
values were 216 ± 4, 226 ± 6, and 202 ± 3 mmHg in the saline
group, the GCE group, and the coﬀee-treated group, respec-
tively. There were no signiﬁcant changes in SBP in the coﬀee
group throughout the experimental period. In contrast, the
GCE-induced SBP change reached a maximum at 12 h. When
caﬀeine was added to GCE to adjust the caﬀeine content
(200 mg/kg) of the coﬀee, SBP was reduced to a level similar
to that shown in Fig. 2 (data not shown).
3.2. Isolation of coﬀee components that inhibit chlorogenic
acid-induced antihypertension
The fractionation procedure and recovery rates in each frac-
tion are shown in Fig. 3A. Chlorogenic acid was eluted in frac-
tion F3, which reduced SBP 12 h after administration to SHR
(data not shown). Following repeated isolation steps using re-
versed phase HPLC on an ODS column and DCC chromatog-
raphy, the F2, F2-1, F2-1-B, and F2-1-B-b fractions wereFig. 3. Isolation of inhibitory components in coﬀee related to chlorogenic acid
ODS-HPLC and DCC. (B) The DCC pattern indicated that the main peak, F
(HHQ). (C) Change in SBP 12 h after a single oral administration of green co
acid (5-CQA, 300 mg/kg) co-administered with HHQ (0.03, 0.3, and 3 mg
**P < 0.01, and ***P < 0.001 versus saline group.found to contain components that inhibited 5-CQA-induced
antihypertension. Changes in SBP at 12 h after the administra-
tion of 5-CQA (200 mg/kg) alone and each of the above frac-
tions were as follows: 12.8 ± 1.3% in the 5-CQA group;
3.4 ± 3.0% in the 5-CQA plus the F2 group; 2.3 ± 0.5 %
in the 5-CQA plus the F2-1 group; 3.5 ± 1.2% in the 5-
CQA plus the F2-1-B group; and 3.7 ± 1.2% in the 5-CQA
plus the F2-1-B-b group. These fractions signiﬁcantly inhibited
the hypotensive eﬀect of 5-CQA (P < 0.05). On the HPLC
chromatogram (Fig. 3B) and three-dimensional spectrum (data
not shown), the main peak of the F2-1-B-b fraction was iden-
tical to that of standard HHQ. The F2-1-B-b fraction con-
tained approximately 40% HHQ. The high-polarity and lack-induced antihypertension. (A) Puriﬁcation of coﬀee by reversed phase
2-1-B-b, corresponded to an authentic sample of hydroxyhydroquinone
ﬀee bean extract (GCE, 300 mg/kg chlorogenic acid) or 5-caﬀeoylquinic
/kg) in SHR. The results are the means ± S.E.M. (n = 6). *P < 0.05,
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gested that mono- and disaccharides were also present in the
F2-1-B-b fraction. The SBP reducing eﬀects of a single oral
administration of GCE (300 mg/kg of chlorogenic acid) or 5-
CQA (300 mg/kg) were signiﬁcantly inhibited by the concomi-
tant ingestion of HHQ in a dose-dependent manner (Fig. 3C).
3.3. Eﬀects of oral administration of HHQ-free coﬀee in SHR
After conﬁrming the removal of HHQ by HPLC, we orally
administered HHQ-free coﬀee to SHR. HHQ-free coﬀee signif-
icantly decreased SBP at 12 h after its administration
(Fig. 4A). It is noteworthy that the co-administration of
HHQ (3 mg/kg) or the administration of the NO synthase
inhibitor L-NAME with the HHQ-free coﬀee signiﬁcantly
inhibited the HHQ-free coﬀee-induced antihypertensive eﬀect
in SHR. When HHQ-free coﬀee was orally administered for
a period of 8 weeks to SHR, the increase in SBP was signiﬁ-
cantly inhibited in the HHQ-free coﬀee group compared to
the control diet group (Fig. 4B). The levels of expression of the
mRNA of NAD(P)H oxidase components Nox-2, p22phox,
and p47phox in the aorta were signiﬁcantly suppressed as the
result of the HHQ-free coﬀee treatment compared to the con-
trol diet group (Fig. 4C). In SHR aortas, acetylcholine-induced
endothelium-dependent vasodilation was signiﬁcantly im-Fig. 4. Eﬀects of an oral administration of HHQ-free coﬀee (HFC) in SHR.
coﬀee (300 mg/kg chlorogenic acid) co-administered with HHQ (3 mg/kg) or L
*P < 0.05 versus saline group. #P < 0.05 versus HHQ-free coﬀee group. (B) Eﬀ
8-week experimental period. HHQ-free coﬀee diet (approximately 300 mg/kg
(C) Eﬀect of the continuous intake of HHQ-free coﬀee on the mRNA expre
Eight weeks after treatment with HHQ-free coﬀee, mRNA expression was me
intake of HHQ-free coﬀee on the endothelium-dependent vasodilatory respon
represents the mean ± S.E.M., n = 6. *P < 0.05 versus control diet group.proved in the HHQ-free coﬀee diet group compared to the
control diet group (Fig. 4D). At the end of the 8-week study
period, no signiﬁcant diﬀerences were found in daily food in-
take (23.2 ± 1.8 g and 22.5 ± 0.1 g) and body weight
(375 ± 6 g and 377 ± 8 g) between the HHQ-free coﬀee diet
group and the control diet group, respectively.4. Discussion
The literature contains conﬂicting reports on the eﬀect of
coﬀee intake on blood pressure [13,14]. Blood pressure rises
after coﬀee consumption in non-habitual coﬀee drinkers,
whereas the eﬀect of coﬀee on blood pressure is smaller or
not detectable in habitual coﬀee drinkers [14]. In SHR, we
demonstrated that a single administration of a coﬀee solution
had little eﬀect on SBP, while GCE signiﬁcantly decreased SBP
in spite of the presence of caﬀeine. This suggests that the anti-
hypertensive components of coﬀee are inhibited by some other,
as yet unidentiﬁed component in coﬀee. The fraction contain-
ing HHQ signiﬁcantly inhibited the hypotensive eﬀect of chlor-
ogenic acid. Of note is the ﬁnding that HHQ clearly inhibited
the chlorogenic acid-induced antihypertension in a dose-
dependent manner. The amount of chlorogenic acid in coﬀee(A) Change in SBP 12 h after a single oral administration of HHQ-free
-NAME (3 mg/kg) in SHR. The results are the means ± S.E.M. (n = 6).
ect of continuous intake of HHQ-free coﬀee on SBP in SHR during the
/d chlorogenic acid) signiﬁcantly inhibited the increase in SBP in SHR.
ssion of NAD(P)H oxidase components Nox-2, p22phox, and p47phox.
asured in SHR aortas using real-time PCR. (D) Eﬀect of the continuous
se to acetylcholine in thoracic aortic rings from SHR. (B–D) Each value
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20 mg/kg [20]; thus, the ratio of HHQ/chlorogenic acid is
approximately 1/100, which is the same ratio of HHQ (3 mg/
kg) and chlorogenic acid (300 mg/kg) used in the present study
(Fig. 3C). Collectively, these ﬁndings suggest that HHQ is the
main component in coﬀee that inhibits chlorogenic acid-
induced antihypertension.
A single oral ingestion of HHQ-free coﬀee led to a signiﬁcant
decrease in blood pressure, which was blocked by pretreatment
with L-NAME, suggesting the involvement of NO in the
mechanism of action. Since the antihypertensive eﬀect of chlor-
ogenic acid is reported to be associated with NO [11], a possi-
ble candidate for the active substance in HHQ-free coﬀee is
chlorogenic acid. Chlorogenic acid in coﬀee might mainly be
degraded by microﬂora elastases in the large intestine, and
then absorbed as caﬀeic and ferulic acids [21]. Caﬀeic acid re-
duces cell proliferation through the Janus kinase/signal trans-
ducer and activators of transcription and the Ras/Raf/
ERK1/2 pathways, followed by the down-regulation of
NADPH oxidase activity in angiotensin II-induced vascular
smooth muscle cells in stroke-prone SHR [22,23]. In addition,
we previously reported that the hypotensive eﬀect of ferulic
acid is inhibited by pretreatment with an NO synthase inhibi-
tor, but not a cyclooxygenase inhibitor, a b- and an a-adreno-
ceptor antagonist, or a calcium channel blocker [24]. Thus,
coﬀee metabolites, such as caﬀeic and ferulic acids, appear to
improve vascular function through reducing ROS production
and enhancing the bioavailability of NO.
The production of O2 and hydrogen peroxide (H2O2) by
HHQ has been conﬁrmed in vitro and in vivo [16,20]. The
eﬀects of H2O2 on vascular reactivity are controversial.
H2O2 has been reported to act as an endothelium-derived
hyperpolarizing factor in physiological levels in resistant
arteries [25]. On the other hand, H2O2 (0.1–10 mM) has
been reported to induce the contractile response in intrapul-
monary arteries [26]. In the present study, a single HHQ
treatment (3 mg/kg) failed to change the blood pressure in
SHR; the change in SBP was 4 ± 1% 12 h after the admin-
istration that was not signiﬁcantly diﬀerent compared with
the saline group. Thus, HHQ-derived H2O2 is less likely to
contribute to the regulation of blood pressure, based on
the results of this experiment. Collectively, the above ﬁnd-
ings suggest that HHQ-derived O2 might mainly inhibit
the chlorogenic acid-induced increase in NO activity. Be-
cause HHQ-free coﬀee improved endothelium-dependent
vasodilation, an eﬀect that was accompanied by a reduction
in the levels of NAD(P)H oxidase mRNA, the possibility
that HHQ-derived O2 inhibited the coﬀee chlorogenic acid-
induced increase in NO bioavailability cannot be excluded.
More detailed experimentation will be needed, however, to
determine the mechanism of action of HHQ-free coﬀee
and physiological interactions of coﬀee components, HHQ,
chlorogenic acid, and others.
In summary, HHQ, a prooxidant component of roasted cof-
fee, clearly inhibited the antihypertensive eﬀect of chlorogenic
acid. The removal of low molecular weight components includ-
ing HHQ by treatment with activated charcoal might allow the
chlorogenic acid present in coﬀee to exert a hypotensive eﬀect.
The attenuation of hypertension by HHQ-free coﬀee was asso-
ciated with the suppression of NAD(P)H oxidase mRNA
expression and the improvement in endothelium-dependent
vasodilation in SHR aortas. Accordingly, HHQ-free coﬀeemight help to minimize vascular injury through its ability to
improve hypertension and endothelial function.References
[1] Cai, H. and Harrison, D.G. (2000) Endothelial dysfunction in
cardiovascular diseases: the role of oxidant stress. Circ. Res. 87,
840–844.
[2] Touyz, R.M. (2004) Reactive oxygen species, vascular oxidative
stress, and redox signaling in hypertension: what is the clinical
signiﬁcance? Hypertension 44, 248–252.
[3] Pritchard Jr., K.A., Groszek, L., Smalley, D.M., Sessa, W.C., Wu,
M., Villalon, P., Wolin, M.S. and Stemerman, M.B. (1995) Native
low-density lipoprotein increases endothelial cell nitric oxide
synthase generation of superoxide anion. Circ. Res. 77, 510–518.
[4] Grunfeld, S., Hamilton, C.A., Mesaros, S., McClain, S., Dom-
iniczak, A.F., Bohr, D.F. and Malinski, T. (1995) Role of
superoxide in the depressed nitric oxide production by the
endothelium of genetically hypertensive rats. Hypertension 26,
854–857.
[5] Bazzano, L.A., He, J., Ogden, L.G., Loria, C.M., Vupputuri, S.,
Myers, L. and Whelton, P.K. (2002) Fruit and vegetable intake
and risk of cardiovascular disease in US adults: the ﬁrst National
Health and Nutrition Examination Survey Epidemiologic Follow-
up Study. Am. J. Clin. Nutr. 76, 93–99.
[6] Niggeweg, R., Michael, A.J. and Martin, C. (2004) Engineering
plants with increased levels of the antioxidant chlorogenic acid.
Nat. Biotechnol. 22, 746–754.
[7] Minamisawa, M., Yoshida, S. and Takai, N. (2004) Determina-
tion of biologically active substances in roasted coﬀees using a
diode-array HPLC system. Anal. Sci. 20, 325–328.
[8] Cliﬀord, M.N., Johnston, K.L., Knight, S. and Kuhnert, N.
(2003) Hierarchical scheme for LC-MSn identiﬁcation of chlor-
ogenic acids. J. Agric. Food Chem. 51, 2900–2911.
[9] Saito, I., Tsuchida, T., Watanabe, T., Arai, Y., Mitsui, Y.,
Okawa, W. and Kajihara, Y. (2002) Eﬀect of coﬀee bean extract
in essential hypertension. Jpn. J. Med. Pharm. Sci. 47, 67–74.
[10] Kozuma, K., Tsuchiya, S., Kohori, J., Hase, T. and Tokimitsu, I.
(2005) Antihypertensive eﬀect of green coﬀee bean extract on
mildly hypertensive subjects. Hypertens. Res. 28, 711–718.
[11] Suzuki, A., Kagawa, D., Ochiai, R., Tokimitsu, I. and Saito, I.
(2002) Green coﬀee bean extract and its metabolites have a
hypotensive eﬀect in spontaneously hypertensive rats. Hypertens.
Res. 25, 99–107.
[12] Ochiai, R., Jokura, H., Suzuki, A., Tokimitsu, I., Ohishi, M.,
Komai, N., Rakugi, H. and Ogihara, T. (2004) Green coﬀee bean
extract improves human vasoreactivity. Hypertens. Res. 27, 731–
737.
[13] Corti, R., Binggeli, C., Sudano, I., Spieker, L., Hanseler, E.,
Ruschitzka, F., Chaplin, W.F., Luscher, T.F. and Noll, G. (2002)
Coﬀee acutely increases sympathetic nerve activity and blood
pressure independently of caﬀeine content: role of habitual versus
nonhabitual drinking. Circulation 106, 2935–2940.
[14] Noordzij, M., Uiterwaal, C.S., Arends, L.R., Kok, F.J., Grobbee,
D.E. and Geleijnse, J.M. (2005) Blood pressure response to
chronic intake of coﬀee and caﬀeine: a meta-analysis of random-
ized controlled trials. J. Hypertens. 23, 921–928.
[15] Vlachopoulos, C., Panagiotakos, D., Ioakeimidis, N., Dima, I.
and Stefanadis, C. (2005) Chronic coﬀee consumption has a
detrimental eﬀect on aortic stiﬀness and wave reﬂections. Am. J.
Clin. Nutr. 81, 1307–1312.
[16] Halliwell, B., Long, L.H., Yee, T.P., Lim, S. and Kelly, R. (2004)
Establishing biomarkers of oxidative stress: the measurement of
hydrogen peroxide in human urine. Curr. Med. Chem. 11, 1085–
1092.
[17] Cuzzocrea, S., Mazzon, E., Dugo, L., Di Paola, R., Caputi, A.P.
and Salvemini, D. (2004) Superoxide: a key player in hyperten-
sion. FASEB J. 18, 94–101.
[18] Ulker, S., McKeown, P.P. and Bayraktutan, U. (2003) Vitamins
reverse endothelial dysfunction through regulation of eNOS and
NAD(P)H oxidase activities. Hypertension 41, 534–539.
[19] Wakino, S., Hayashi, K., Tatematsu, S., Hasegawa, K., Takama-
tsu, I., Kanda, T., Homma, K., Yoshioka, K., Sugano, N. and
Saruta, T. (2005) Pioglitazone lowers systemic asymmetric dime-
2322 A. Suzuki et al. / FEBS Letters 580 (2006) 2317–2322thylarginine by inducing dimethylarginine dimethylaminohydro-
lase in rats. Hypertens. Res. 28, 255–262.
[20] Hiramoto, K., Li, X., Makimoto, M., Kato, T. and Kikugawa, K.
(1998) Identiﬁcation of hydroxyhydroquinone in coﬀee as a
generator of reactive oxygen species that break DNA single
strands. Mutat. Res. 419, 43–51.
[21] Mursu, J., Voutilainen, S., Nurmi, T., Alfthan, G., Virtanen, J.K.,
Rissanen, T.H., Happonen, P., Nyyssonen, K., Kaikkonen, J.,
Salonen, R. and Salonen, J.T. (2005) The eﬀects of coﬀee
consumption on lipid peroxidation and plasma total homocyste-
ine concentrations: a clinical trial. Free Radic. Biol. Med. 38, 527–
534.
[22] Xu, J.W., Ikeda, K., Kobayakawa, A., Ikami, T., Kayano, Y.,
Mitani, T. and Yamori, Y. (2005) Downregulation of Rac1
activation by caﬀeic acid in aortic smooth muscle cells. Life Sci.
76, 2861–2872.[23] Li, P.G., Xu, J.W., Ikeda, K., Kobayakawa, A., Kayano, Y.,
Mitani, T., Ikami, T. and Yamori, Y. (2005) Caﬀeic acid inhibits
vascular smooth muscle cell proliferation induced by angiotensin
II in stroke-prone spontaneously hypertensive rats. Hypertens.
Res. 28, 369–377.
[24] Suzuki, A., Kagawa, D., Fujii, A., Ochiai, R., Tokimitsu, I. and
Saito, I. (2002) Short- and long-term eﬀects of ferulic acid on
blood pressure in spontaneously hypertensive rats. Am. J.
Hypertens. 15, 351–357.
[25] Shimokawa, H. and Matoba, T. (2004) Hydrogen peroxide as an
endothelium-derived hyperpolarizing factor. Pharmacol. Res. 49,
543–549.
[26] Sheehan, D.W., Giese, E.C., Gugino, S.F. and Russell, J.A.
(1993) Characterization and mechanisms of H2O2-induced con-
tractions of pulmonary arteries. Am. J. Physiol. 264, H1542–
H1547.
